Evidence map›Paper›PMID 18513646›Full record

Trial reportJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Individual differences in the effectiveness of intracoronary bone marrow cell transplantation assessed by gated sestamibi SPECT/FDG PET imaging.

Milan Kaminek, Jaroslav Meluzin, Roman Panovsky, Stanislav Janousek, Jiri Mayer, Jiri Prasek, Jaroslav Stanicek, Jan Lukl

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Stem cell treatment for acute myocardial infarction.The Cochrane database of systematic reviews · 2015
    Pooled it
  3. The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2014
    Pooled it
  4. Trial
  5. Structural aspects of Golgi function.Cellular and molecular life sciences : CMLS · 2004
    Review
  6. Can radionuclide imaging predict future response to stem cell therapy?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Milan KaminekDepartment of Nuclear Medicine, University Hospital Olomouc, Czech Republic. milankaminek@seznam.cz
Jaroslav Meluzin
Roman Panovsky
Stanislav Janousek
Jiri Mayer
Jiri Prasek
Jaroslav Stanicek
Jan Lukl
Masaryk University · CZUniversity Hospital Olomouc · CZMasaryk Memorial Cancer Institute · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe impact of different levels of tracer uptake on improvements of left-ventricular (LV) function was analyzed in patients treated by intracoronary bone marrow cell (BMC) transplantation. METHODS AND

resultsThirty-one patients with irreversible damage after their first acute myocardial infarction (MI), as confirmed by sestamibi single-photon emission computed tomography (MIBI SPECT)/fluorodeoxyglucose positron emission tomography (FDG PET), underwent high-dose (1 x 10(8) cells) BMC transplantation, whereas 31 similar patients were randomly integrated into a control group. In 11 BMC-treated patients with very low sestamibi uptake at less than 30% of maximum in the infarcted area, the mean left-ventricular ejection fraction (LVEF) improved after 3 months of follow-up by 3% only, and mean end-diastolic/end-systolic volumes (EDV/ESV) enlarged by 10/1 mL (P = NS vs controls). In 20 BMC-treated patients with higher sestamibi uptake in the range of 31% to 50% of maximum, LVEF improved by 7%, and EDV/ESV decreased by 5/12 mL (P < .05 vs BMC-treated subgroup with low MIBI uptake and controls). No similar categorization was seen in the control group: in patients with higher sestamibi uptake or very low uptake, the LVEF increased by 2% and 3% only, and the EDV/ESV enlarged in both subgroups by 12/4 mL and 12/2 mL, respectively (P = NS).

conclusionsOur results suggest the capability of SPECT/PET imaging to select patients who will receive the maximum benefit from BMC therapy.

Indexed as

Fluorodeoxyglucose F18Bone Marrow TransplantationCoronary VesselsFemaleHumansMaleMiddle AgedMyocardial InfarctionOutcome Assessment, Health CarePositron-Emission TomographyRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonTreatment OutcomeVentricular Dysfunction, LeftFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID18513646
OpenAlexW2029740051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.